Kamaljit Kaur

Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial

Christopher Elnan Kvistad, Halvor Næss, Bernt Harald Helleberg et al. · The Lancet Neurology · 2022 · 205 citations

Medicine, Neurology, Good Clinical Practice +10

(Carboxyalkyl)pyrroles in Human Plasma and Oxidized Low-Density Lipoproteins

Kamaljit Kaur, Robert G. Salomon, June O’Neil et al. · Chemical Research in Toxicology · 1997 · 109 citations

Life Sciences, Biochemistry, Molecular Biology +15

Isolevuglandin–protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway

Robert G. Salomon, Eugenia Batyreva, Kamaljit Kaur et al. · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 2000 · 79 citations

Life Sciences, Biochemistry, Toxicology +16

Protein Adducts of Iso[4]levuglandin E2, a Product of the Isoprostane Pathway, in Oxidized Low Density Lipoprotein

Robert G. Salomon, Wei Sha, Cynthia J. Brame et al. · Journal of Biological Chemistry · 1999 · 54 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15